Abstract LBA003: Erdafitinib in patients with tumors harboring FGFR gene mutations or fusions: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol K2
Year: 2021
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Alain C Mita, Zihan Wei, Ingrid A Mayer, Heather Cheng, Edith P Mitchell, John J Wright, Percy Ivy, Robert J Gray, Victoria Wang, Lisa M McShane, Larry V Rubinstein, David R Patton, Mickey Williams, Stanley R Hamilton, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Institutions: Cedars-Sinai Medical Center, Dana-Farber Cancer Institute, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, University of Washington, Sidney Kimmel Cancer Center, National Cancer Institute, City Of Hope National Medical Center, The University of Texas Southwestern Medical Center, University of Pennsylvania, Massachusetts General Hospital
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4200325253